ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements with these filters
Rainbow Childrens Medicare delivered its highest quarterly revenue and 20% YoY growth despite significant recent bed capacity additions. Management transitions are smooth with a focus on improving occupancies and clinical excellence.
Rainbow Childrens Medicare re-appointed four directors, including its MD and Chairperson, for five-year terms. These leadership extensions ensure management continuity and governance stability for investors.
Rainbow Children's Medicare approved its FY26 audited results and recommended a ₹3.50 per share dividend. Key leadership re-appointments were also cleared during the board meeting.
Rainbow Children's Medicare granted 2,67,550 stock options to employees under its ESOP Scheme 2025. This long-term incentive program aligns employee interests with shareholder value creation.
Rainbow Children’s Medicare Limited reported strong Q4 FY26 performance with 24% YoY revenue growth and 26% EBITDA growth. Strategy focuses on deepening the 'Hub and Spoke' model across major Indian cities.
Rainbow Childrens Medicare recommended a final dividend of Rs. 3.50 per share for FY2026. The record date is July 21, 2026, with payment by August 27.
Rainbow Children’s Medicare reported strong Q4 results with 24.3% revenue growth. The company completed its capacity expansion phase, shifting focus to execution and operational optimization.
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹459.9 Cr (+24.3% YoY) and net profit of ₹78.2 Cr (+38.2% YoY) for Q4 FY26.
Rainbow Childrens Medicare reported audited FY26 results and recommended a ₹35.55 Crore final dividend. The board also approved several key director re-appointments for five-year terms.
Rainbow Children's Medicare Limited submitted its Annual Secretarial Compliance Report for the fiscal year 2026. The report confirms overall regulatory adherence with no material non-compliances noted.
Rainbow Children’s Medicare received an order upholding a prior GST demand notice. The company is now preparing an appeal before the appropriate higher authority.
Rainbow Children’s Medicare Limited inaugurated a new 60-bed spoke hospital and a dedicated IVF centre in Bengaluru for ₹52 Crore. Funded through internal accruals, this expansion increases the company's total bed capacity to ~2,435 beds. The facilities strengthen Rainbow's hub-and-spoke network in high-growth Karnataka micro-markets.
White Oak Capital Management Consultants LLP sold 20,38,948 shares (2.01%) of Rainbow Children's Medicare Ltd. This disposal follows a business transfer and reduces their total holding from 4.81% to 2.80%.
Rainbow Children's Medicare Ltd clarified to the BSE that the recent movement in its trading volume is market-driven. The company confirmed it has no undisclosed material information or unpublished price-sensitive information (UPSI) that could impact price or volume behavior, maintaining its commitment to regulatory compliance.
Rainbow Children's Medicare clarified that recent significant trading volume movements are market-driven and not due to any undisclosed material information. The company confirmed compliance with SEBI listing regulations and reiterated that no unpublished price-sensitive information exists.